Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,641 public trials 847 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Active, Not Recruiting

DA-EPOCH-R Induction Followed by Nivolumab Consolidation in Newly Diagnosed MYC, BCL2 and/or BCL6 Rearranged HGBL

NCT03620578

Conditions
BCL-2 Translocation, Hemic and Lymphatic Diseases, High-grade B-cell Lymphoma, +11 more
Locations
  • BE-Antwerpen-ZNASTUIVENBERG Antwerp, Belgium
  • BE-Leuven-UZLEUVEN Leuven, Belgium
  • NL-Den Bosch-JBZ 's-Hertogenbosch, Netherlands
  • NL-Almere-FLEVOZIEKENHUIS Almere Stad, Netherlands
View all 24 locations
View Trial Details
Active, Not Recruiting

Acalabrutinib and Rituximab in Elderly Patients With Untreated Mantle Cell Lymphoma

NCT05214183

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Department of Hematology X, Odense University Hospital Odense, Denmark
  • Department of Hematology, Zeeland University Hospital Roskilde Roskilde, Denmark
  • Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center Helsinki, Finland
  • Oulu University Hospital Oulu, Finland
View all 20 locations
View Trial Details
Active, Not Recruiting

CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Mantle Cell Lymphoma

NCT04718883

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Peking University Cancer Hospital Beijing, Beijing Municipality, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Fujian Medical University Consonancy Hospital Fuzhou, Fujiang, China
  • Guangdong Province people hospital Guanzhou, Guangdong, China
View Trial Details
Active, Not Recruiting

Phase I Study of Inotuzumab With Augmented BFM Re-Induction for Patients With Relapsed/Refractory B-cell ALL

NCT03962465

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
  • University of Virginia Charlottesville, Virginia, United States
  • VCU Massey Cancer Center Richmond, Virginia, United States
  • University of Wisconsin Madison, Wisconsin, United States
View Trial Details
Active, Not Recruiting

Phase 1 Study of Autologous CD30.CAR-T in Relapsed or Refractory CD30 Positive Non-Hodgkin Lymphoma

NCT04526834

Conditions
Anaplastic Large Cell Lymphoma, Diffuse Large B Cell Lymphoma, Extranodal NK/T-cell Lymphoma, +17 more
Locations
  • City of Hope Duarte, California, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • Baylor College of Medicine Houston, Texas, United States
  • The University of Texas MD Anderson Cancer Centre Houston, Texas, United States
View Trial Details
Active, Not Recruiting

Phase 2 Study Evaluating Autologous CD30.CAR-T Cells in Patients With Relapsed/Refractory Hodgkin Lymphoma (CHARIOT)

NCT04268706

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Disease Recurrent, +10 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
View Trial Details
Active, Not Recruiting

Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant

NCT03301168

Conditions
Acute Lymphoblastic Leukemia, Anemia, Anemia, Aplastic, +34 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Stanford University - Division of Pediatric Stem Cell Transplant & Regenerative Medicine Palo Alto, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
View Trial Details
Active, Not Recruiting

Multi-Center Study of Sensory Stimulation to Improve Brain Function

NCT03556280

Conditions
Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +26 more
Locations
  • Brain Matters Research Delray Beach, Florida, United States
  • Brain Matters Research Stuart, Florida, United States
  • ActivMed Practices & Research, Inc Methuen, Massachusetts, United States
  • Boston Center for Memory Newton, Massachusetts, United States
View Trial Details

Related conditions